乌鸦传媒

<乌鸦传媒 class='mpt-top_cat_title'>Oncology/Hematology >

Hematology

News, opinions and meeting coverage in oncology/hematology.

A photo of a male artist tattooing his male client in a parlor in Stockholm, Sweden.

<乌鸦传媒>Tattoos May Be a Risk Factor for Lymphoma

Swedish study suggests a 21% higher risk for lymphoma in those with tattoos

The YouTube thumbnail for this video with a cartoon nurse and the words: MOST BURNT OUT SPECIALTY

<乌鸦传媒>Five Doctor 乌鸦传媒 With the Most Burnout in 2024

Emergency medicine and ob/gyn top the list

A computer rendering of antibodies in the blood.

<乌鸦传媒>Doubt Cast on MGUS-Autoimmune Disease Link

Population-based study fails to confirm earlier findings

A photo of infected blood victim Brendan West.

<乌鸦传媒>What to Know About the U.K.'s Tainted Blood Scandal

Tens of thousands contracted HIV or hepatitis from transfusions during the 1970s and 1980s

<乌鸦传媒>Mortality in U.S. Youth; Gene Therapy for Sickle Cell Disease

Also in TTHealthWatch: updated breast cancer screening guidelines

Onco Break over a computer rendering of a cancer cell.

<乌鸦传媒>Cancer Vaccines' Emergence; More Focus on Side Effects; A Nudge for Exercise

News, features, and commentary about cancer-related issues

A computer rendering of acute myeloid leukemia cells in the blood.

<乌鸦传媒>Venetoclax Combo Safe, Effective in AML Patients Age 80 and Up, Real-World Data Show

Study finds survival is comparable to that seen in younger patients in VIALE-A trial

A photo of a box of Adzynma

<乌鸦传媒>Impact of Recombinant Replacement Therapy Detailed in Genetic Clotting Disorder

Trial that led to FDA approval shows a big difference in replacement levels versus usual care

A photo of a lab technician using a pipette to transfer a sample to a multi well plate in a laboratory.

<乌鸦传媒>Genetics and Genetic Testing to Inform Myelofibrosis Clinical Management

Genetics already informs prognosis, may help guide therapy development beyond JAK2 inhibition

A computer rendering of Myelofibrosis cells in the blood

<乌鸦传媒>Myelofibrosis: A Rare Malignancy Attracting More and More Attention

Increased interest follows mutation discoveries, development of targeted therapies

Morning Break over illustration of a syringe, Covid virus, and DNA helix over a photo of green vegetation.

<乌鸦传媒>New E. Coli Outbreak; How ECMO Redefines Death; A Step Closer to Universal Blood

Health news and commentary gathered by 乌鸦传媒 staff

FDA APPROVED mavorixafor (Xolremdi) over a photo of warts on a woman鈥檚 hand.

<乌鸦传媒>FDA Approves First Drug for WHIM Syndrome

CXCR4 antagonist mavorixafor effectively boosts neutrophils and lymphocytes to reduce infections

Onco Break over a computer rendering of a cancer cell.

<乌鸦传媒>Clue to Aspirin, Colon Cancer Link; New Lutathera Approval; AI & Electronic Records

News, features, and commentary about cancer-related issues

Illustration of red blood cells.

<乌鸦传媒>FDA OKs Second Gene Therapy for Hemophilia B

One dose of fidanacogene elaparvovec proved noninferior to standard prophylactic factor IX

An image of isatuximab tablets.

<乌鸦传媒>Quadruplet Shows 'Excellent Activity' in Myeloma Patients Who Defer HSCT

ORR reaches 90% with isatuximab plus KRd in newly diagnosed disease

Illustration of blood cells with circulating tumor cells.

<乌鸦传媒>High Deep-Remission Rate With Triple Regimen for Relapsed/Refractory CLL

Undetectable disease rate over 90%, ctDNA also promising for earlier detection of recurrence

Illustration of an engineered T-cell attacking a leukemia cell.

<乌鸦传媒>CAR-T Plus Stem-Cell Transplant Promising for CD7+ Blood Cancers

"All-in-one" approach appears safe, effective, in patients with relapsed/refractory disease

A photo of a pregnant woman napping while receiving chemotherapy.

<乌鸦传媒>Immunotherapy During Pregnancy Just as Safe as Other Cancer Drugs

However, use should be avoided "if possible" due to risk of rare immune-related adverse events

FDA APPROVED ciltacabtagene autoleucel (Carvykti), idecabtagene vicleucel (Abecma) over 3D multiple myeloma cells.

<乌鸦传媒>FDA Approves Earlier Use of CAR-T Products for Myeloma

Carvykti and Abecma move to second- and third-line, respectively

ACC over a photo of Georgia World Congress Center in Atlanta, GA

<乌鸦传媒>High Response Rate in R/R Multiple Myeloma With Bispecific Antibody

ORR of 71% that deepened over time and favorable safety profile with linvoseltamab

FDA APPROVED danicopan (Voydeya) over a computer rendering of red blood cells.

<乌鸦传媒>Factor D Inhibitor Wins Approval for PNH With Extravascular Hemolysis

Danicopan significantly improved hemoglobin at 12 weeks when added to a C5 inhibitor

FDA APPROVED ceftobiprole medocaril sodium (Zevtera) over a computer rendering of Staphylococcus aureus bacteria

<乌鸦传媒>FDA OKs Injectable Antibiotic for Three Different Uses

Ceftobiprole was at least comparable to currently used medications in studies

Onco Break over a computer rendering of a cancer cell.

<乌鸦传媒>Chemo and Heart Disease; Flawed Lung Cancer Screening; New Vax Recommendations

News, features, and commentary about cancer-related issues

A computer rendering of white blood cells with T-cell lymphoma.

<乌鸦传媒>PD-1 Inhibitor Plus Chemotherapy Shows Promising Activity in Rare Lymphoma

The combination induced responses in all 34 patients with advanced extranodal NK/T-cell lymphoma

A photo of a woman breastfeeding her baby at home.

<乌鸦传媒>Breastfeeding Tied to Reduced Childhood Leukemia Risk

Lower pediatric ALL risk in Danish study when mothers exclusively breastfed for 3 months or more

FDA EUA pemivibart (Pemgarda) over a computer rendering of antibodies attacking COVID viruses.

<乌鸦传媒>New Monoclonal Authorized to Prevent COVID in Immunocompromised People

No such option has been available since FDA revoked the authorization of Evusheld last year

FDA APPROVED ponatinib (Iclusig) over a computer rendering of the destruction of lymphoblast cells

<乌鸦传媒>FDA Approves New Frontline Regimen for Aggressive ALL

Ponatinib lands indication in combination with chemo for Philadelphia chromosome-positive cases

Onco Break over a computer rendering of a cancer cell.

<乌鸦传媒>Broader Cancer Risk With CAR-T? AI for Physician Burnout; 'Lollipops' ID Oral Cancer

News, features, and commentary about cancer-related issues

A photo of a woman reading a book while receiving chemotherapy

<乌鸦传媒>Long-Term Breast Cancer Risk in Hodgkin Lymphoma Survivors Treated With Doxorubicin

Dose-dependent increase regardless of age at treatment or chest radiotherapy

FDA ODAC ciltacabtagene autoleucel (cilta-cel, Carvykti) and idecabtagene vicleucel (ide-cel, Abecma) over multiple myeloma.

<乌鸦传媒>FDA Panel Gives Thumbs Up to Earlier Use of CAR T-Cell Therapy in Multiple Myeloma

Cilta-cel, ide-cel win support despite concerns about early mortality risk

FDA APPROVED lisocabtagene maraleucel (Breyanzi) over a computer rendering of CLL cells in the blood stream.

<乌鸦传媒>FDA Approves First CAR-T for Chronic Lymphocytic Leukemia

Lisocabtagene maraleucel (Breyanzi) nabs new indication for relapsed or refractory CLL/SLL

FDA ODAC imetelstat (Rytelo) over a close up photo of a person receiving a blood transfusion.

<乌鸦传媒>FDA Panel Endorses Imetelstat for MDS-Related Anemia

By 12-2 vote, members find improvement in transfusion independence outweighs risk

FDA ODAC ciltacabtagene autoleucel (cilta-cel, Carvykti) and idecabtagene vicleucel (ide-cel, Abecma) over multiple myeloma.

<乌鸦传媒>Early Death Risk Muddies Risk-Benefit Assessment of CAR-T Therapies for Myeloma

FDA advisory panel to weigh the evidence for cilta-cel, ide-cel in day-long meeting

Onco Break over a computer rendering of a cancer cell.

<乌鸦传媒>Getting Prostate Cancer Drugs Sooner; Limiting Toxic Emissions; FTC Sues 'Charity'

News, features, and commentary about cancer-related issues

FDA ODAC imetelstat (Rytelo) over a close up photo of a person receiving a blood transfusion.

<乌鸦传媒>FDA Staff Cast Doubt on Novel Drug for MDS-Related Anemia

Agency asking its advisors if benefits outweigh risks for patients who fail on standard treatment

A computer rendering of sickle cells in the bloodstream

<乌鸦传媒>Sickle Cell Pain Hospitalizations Rose After CDC's Opioid Recs

Agency's 2016 guidance may have contributed to reduced access to opioids, and more pain

Onco Break over a computer rendering of a cancer cell.

<乌鸦传媒>A Blenrep Comeback? Cancer Vaccine for Dogs; U.K. Snubs Enhertu

News, features, and commentary about cancer-related issues

A computer rendering of T-cells attacking a Reed-Sternberg cell in Hodgkin lymphoma.

<乌鸦传媒>Novel Regimens Yield High Response Rates for Older, Hodgkin Lymphoma Patients

Talk of potential cure for some patients with brentuximab plus dacarbazine or nivolumab

A photo of a male technician using a light microscope to inject a sperm into an egg.

<乌鸦传媒>IVF Helps Patients Trying to Build Families. An Alabama Court Put That in Doubt

"Every month that you're not pregnant feels like grief"

A computer rendering of acute myeloid leukemia cells in the blood

<乌鸦传媒>All-Oral AML Regimen Shows Promise for Older, Unfit Patients

Response rate of 64% in newly diagnosed patients, 46% in those with refractory/relapsed disease

3

鈥�